MultiCell Technologies, Inc. (MCET)
Develops experimental medicines and medical devices for neurological disorders, cancer, and heart disease.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
MCET is trading at an extremely low price point. The stock sits above both its 50- and 200-day moving averages, suggesting an upward trend positioning. Analyst coverage appears unavailable for this micro-cap security.
What’s behind the score
Price trendAbove its 50- & 200-day averages
Market cap
$50,009
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—